MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a short peptide first described in the scientific literature in 2015. This product is a synthetic preparation of the 16-residue sequence, supplied in a sealed vial as a lyophilized powder for use by qualified researchers in controlled laboratory settings.
Research background
In published literature, MOTS-c is primarily studied in cell culture and animal models as a tool for investigating mitochondrial signaling, nuclear-mitochondrial communication and the AMPK pathway. These references are provided as scientific background only and do not describe any intended use of this product.
Lot verification
Each vial of MOTS-c carries a lot number linked to its own LIV MORE test results. See the Specification tab for compound data and the Test Results page for batch results.
Research use only. This product is intended solely for in vitro laboratory research by qualified professionals. It is not for human or veterinary use and is not a drug, food, dietary supplement or cosmetic. It has not been approved by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, mitigate or prevent any disease.

